United Cannabis Corporation Enters Licensing Agreement With Vessel Life Science LLC
February 23 2017 - 12:34PM
Access Wire
Agreement Grants Vessel Life Science LLC Exclusive
Distribution Rights to Company's Prana Bio Nutrient Medicinals in
the State of Pennsylvania
DENVER, CO / ACCESSWIRE / February 23, 2017 /
United Cannabis Corporation (OTCQB: CNAB) (the "Company" or "United
Cannabis") today announced that it has signed an exclusive
licensing agreement with Vessel Life Sciences ("VLS") to produce
and distribute its products, including the award-winning Prana Bio
Nutrient Medicinals, throughout Pennsylvania.
Established in 2016, Vessel Life Science LLC is dedicated to
advancing the use of cannabinoids in medicine, with a focus on the
refinement of genetics for medical grade strains of CBD-rich
cannabis plants for the commonwealth of Pennsylvania's patient
base. Founded on the principles of patient-driven results, VLS'
mission is to offer the highest quality of products that
indisputably prove and reinforce the use of medical marijuana for
patient benefits and health advances.
United Cannabis' Prana line offers a wide selections of raw and
active cannabinoid supplements with multiple delivery methods that
have accurately dosed medicine from 1mg to 100mg. These products
and patient-driven programs are designed to help regulate the
body's endogenous endocannabinoid system, perhaps the most
important physiological system in maintaining human health. Prana
products are most effective when used in conjunction with the
extended services provided by the A.C.T. Now Program.
Collin Palmer, CEO of Vessel Life Science, commented on the
agreement, "There is a strong demand for medical cannabis in
Pennsylvania, and we are looking to become a leader in this market.
Our exclusive partnership with United Cannabis and their Prana Bio
Nutrient products will enable us to deliver clean and effective
medicine to thousands of patients in need as soon as Act 16 is
fully implemented."
Tony Verzura, United Cannabis' Chief Technology Officer, went on
to say, "Vessel Life Sciences is ideally suited to bring our
products to Pennsylvania. Their team has over 30 years' combined
experience across the spectrum of the cannabis industry, including
engineered facilities, regulatory compliance, genetics,
cultivation, good manufacturing practices, proprietary extraction
methods, branding, marketing, and wholesale distribution. Their
expertise gives us a distinct competitive advantage as we work to
execute a fast and efficient launch of our Prana products and ACT
Program throughout the state."
About United Cannabis Corporation
The Company's Prana Bio Medicinal products provide patients a
simple, safe, accurate, and easy way to mix match cannabinoids for
therapeutic purpose. These products are broken into 5 easy to use
categories that are available in capsules, sublinguals, and topical
delivery methods. The company uses a patent-pending infusion
process utilizing select fatty acids, lipids, and specific
combination of cannabis derived terpenes to increase
bioavailability. Prana Bio Medicinal products are NON-GMO, ethanol
free, alcohol free, glycerin free, gluten free, 100% naturally
derived, chemical-free, solventless, and hypoallergenic.
For further information, please visit www.unitedcannabis.us.
About Vessel Life Science:
Vessel Life Science's Strategic Pennsylvania MMJ Partners have
been involved with medical cannabis since it was permissible in
California in 1999, turning their focus to Colorado during the
infancy stage of legalized medical cannabis in 2009. With the
benefit of more than 30 years' combined experience, Vessel Life's
partners have accumulated an extensive knowledge base across the
spectrum of the cannabis industry, including engineered facilities,
security, regulatory compliance, genetics, cultivation, good
manufacturing practices (GMP), proprietary extraction methods,
branding, retail operations (SOP), marketing, and wholesale
distribution.
For further information, please visit
www.vessellifescience.com.
Contact: Staff@UnitedCannabis.us
Phone: 303-386-7321
Certain statements in this news release may contain
forward-looking information within the meaning of Rule 175 under
the Securities Act of 1933, and are subject to Rule 3b-6 under the
Securities Exchange Act of 1934, and are subject to the safe harbor
created by those rules. All statements, other than statements of
fact, included in this release, including, without limitation,
statements regarding potential future plans and objectives of the
company, are forward-looking statements that involve risks and
uncertainties. There can be no assurance that such statements will
prove to be accurate and other results and further events could
differ materially from those anticipated in such statements. Future
events and actual results could differ materially from those set
forth in, contemplated by, or underlying the forward-looking
statements.
SOURCE: United Cannabis Corporation